The SU2C Funding Model

Share this:
Like
Email

Like this page on Facebook

We are at a pivotal moment in time, when scientists believe they have—at last—both the knowledge and the technology to make critical breakthroughs in the fight against cancer.

To facilitate these breakthroughs, two key ingredients are needed:

  1. New ways for researchers at different institutions to work together.
  2. Additional funding for that collaboration.

That’s what Stand Up To Cancer is designed to bring about: a unified effort among all scientists and clinicians against a common foe – cancer.

SU2C and the scientists whose work we support have a laser-like focus on developments that can be moved quickly from the lab to the clinic, where they can be used to save patients’ lives.  This part of the cancer research spectrum is called translational research, and SU2C utilizes a team approach on just such projects.  Data is shared across institutions, and scientists long accustomed to competing are encouraged to work together, across disciplines and across Institutions. 

Collaborative, multidisciplinary scientific Dream Teams are the cornerstone of SU2C’s mission to deliver treatments to patients faster.  SU2C currently funds 10 dream teams and 1 International Translational Research Team spanning 92 institutions.  Meet the Dream Teams.

Since December of 2009 SU2C has also awarded smaller high-risk, high-reward Innovative Research Grants to another 26 scientists.  Learn more about Innovative Research Grants.

SU2C’s Scientific Review Committee is committed to finding projects that have a strong potential for breakthrough in a small amount of time.  Read more about SU2C’s Research Model.

Read More about Where The Money Goes.

 

Dream Teams

In America more than 1.2 million new patients are diagnosed with cancer every year. A new cancer is diagnosed every 30 seconds in the United States.